227 related articles for article (PubMed ID: 21284020)
1. Elevation of serum c-reactive protein in patients with OAB and IC/BPS implies chronic inflammation in the urinary bladder.
Chung SD; Liu HT; Lin H; Kuo HC
Neurourol Urodyn; 2011 Mar; 30(3):417-20. PubMed ID: 21284020
[TBL] [Abstract][Full Text] [Related]
2. Urinary nerve growth factor level is increased in patients with interstitial cystitis/bladder pain syndrome and decreased in responders to treatment.
Liu HT; Tyagi P; Chancellor MB; Kuo HC
BJU Int; 2009 Nov; 104(10):1476-81. PubMed ID: 19522864
[TBL] [Abstract][Full Text] [Related]
3. Increased serum nerve growth factor levels in patients with overactive bladder syndrome refractory to antimuscarinic therapy.
Liu HT; Lin H; Kuo HC
Neurourol Urodyn; 2011 Nov; 30(8):1525-9. PubMed ID: 21826717
[TBL] [Abstract][Full Text] [Related]
4. Urinary nerve growth factor but not prostaglandin E2 increases in patients with interstitial cystitis/bladder pain syndrome and detrusor overactivity.
Liu HT; Tyagi P; Chancellor MB; Kuo HC
BJU Int; 2010 Dec; 106(11):1681-5. PubMed ID: 19751258
[TBL] [Abstract][Full Text] [Related]
5. Increased nerve growth factor in neurogenic overactive bladder and interstitial cystitis patients.
Jacobs BL; Smaldone MC; Tyagi V; Philips BJ; Jackman SV; Leng WW; Tyagi P
Can J Urol; 2010 Feb; 17(1):4989-94. PubMed ID: 20156378
[TBL] [Abstract][Full Text] [Related]
6. Urinary nerve growth factor levels are elevated in patients with overactive bladder and do not significantly increase with bladder distention.
Liu HT; Kuo HC
Neurourol Urodyn; 2009; 28(1):78-81. PubMed ID: 19089891
[TBL] [Abstract][Full Text] [Related]
7. Urinary nerve growth factor levels are increased in patients with bladder outlet obstruction with overactive bladder symptoms and reduced after successful medical treatment.
Liu HT; Kuo HC
Urology; 2008 Jul; 72(1):104-8; discussion 108. PubMed ID: 18400272
[TBL] [Abstract][Full Text] [Related]
8. Urinary nerve growth factor correlates with the severity of urgency and pain.
Kim SW; Im YJ; Choi HC; Kang HJ; Kim JY; Kim JH
Int Urogynecol J; 2014 Nov; 25(11):1561-7. PubMed ID: 24866276
[TBL] [Abstract][Full Text] [Related]
9. Differences in mast cell infiltration, E-cadherin, and zonula occludens-1 expression between patients with overactive bladder and interstitial cystitis/bladder pain syndrome.
Liu HT; Shie JH; Chen SH; Wang YS; Kuo HC
Urology; 2012 Jul; 80(1):225.e13-8. PubMed ID: 22521193
[TBL] [Abstract][Full Text] [Related]
10. Increased urine and serum nerve growth factor levels in interstitial cystitis suggest chronic inflammation is involved in the pathogenesis of disease.
Liu HT; Kuo HC
PLoS One; 2012; 7(9):e44687. PubMed ID: 23028581
[TBL] [Abstract][Full Text] [Related]
11. Urinary nerve growth factor levels could be a biomarker for overactive bladder symptom: a meta-analysis.
Qu HC; Yan S; Zhang XL; Zhu XW; Liu YL; Wang P
Genet Mol Res; 2014 Apr; 13(4):8609-19. PubMed ID: 24782215
[TBL] [Abstract][Full Text] [Related]
12. Urine nerve growth factor (NGF) level, bladder nerve staining and symptom/problem scores in patients with interstitial cystitis.
Tonyali S; Ates D; Akbiyik F; Kankaya D; Baydar D; Ergen A
Adv Clin Exp Med; 2018 Feb; 27(2):159-163. PubMed ID: 29521057
[TBL] [Abstract][Full Text] [Related]
13. Symptomatic overlap in overactive bladder and interstitial cystitis/bladder pain syndrome: development of a new algorithm.
Ackerman AL; Lai HH; Parameshwar PS; Eilber KS; Anger JT
BJU Int; 2019 Apr; 123(4):682-693. PubMed ID: 30253040
[TBL] [Abstract][Full Text] [Related]
14. Bladder pain syndrome/interstitial cystitis increase the risk of coronary heart disease.
Chen HM; Lin CC; Kang CS; Lee CT; Lin HC; Chung SD
Neurourol Urodyn; 2014 Jun; 33(5):511-5. PubMed ID: 23813657
[TBL] [Abstract][Full Text] [Related]
15. Correlation of urinary nerve growth factor level with pathogenesis of overactive bladder.
Yokoyama T; Kumon H; Nagai A
Neurourol Urodyn; 2008; 27(5):417-20. PubMed ID: 17924444
[TBL] [Abstract][Full Text] [Related]
16. Increased pro-inflammatory cytokines, C-reactive protein and nerve growth factor expressions in serum of patients with interstitial cystitis/bladder pain syndrome.
Jiang YH; Peng CH; Liu HT; Kuo HC
PLoS One; 2013; 8(10):e76779. PubMed ID: 24146927
[TBL] [Abstract][Full Text] [Related]
17. Differences in Urodynamic Parameters Between Women With Interstitial Cystitis and/or Bladder Pain Syndrome and Severe Overactive Bladder.
Shim JS; Kang SG; Park JY; Bae JH; Kang SH; Park HS; Moon du G; Cheon J; Lee JG; Kim JJ; Oh MM
Urology; 2016 Aug; 94():64-9. PubMed ID: 27130264
[TBL] [Abstract][Full Text] [Related]
18. Multifactorial causes of irritating bladder symptoms in patients with Sjögren's syndrome.
Lee KL; Dong CS; Chen MY; Ho CH; Tai HC; Hung SF; Yu HJ
Neurourol Urodyn; 2011 Jan; 30(1):97-101. PubMed ID: 20928912
[TBL] [Abstract][Full Text] [Related]
19. Urgency and pain in patients with overactive bladder and bladder pain syndrome. What are the differences?
Castro-Diaz D; Cardozo L; Chapple CR; Espuña M; Kelleher C; Kirby M; Milsom I; Sievert KD; Tubaro A
Int J Clin Pract; 2014 Mar; 68(3):356-62. PubMed ID: 24373133
[TBL] [Abstract][Full Text] [Related]
20. Urinary nerve growth factor is a better biomarker than detrusor wall thickness for the assessment of overactive bladder with incontinence.
Kuo HC; Liu HT; Chancellor MB
Neurourol Urodyn; 2010 Mar; 29(3):482-7. PubMed ID: 19367641
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
